Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus.
about
Uridine prevents fenofibrate-induced fatty liverNetwork signatures link hepatic effects of anti-diabetic interventions with systemic disease parametersFenofibrate and Diabetic Retinopathy.Peroxisome proliferator-activated receptor α activation induces hepatic steatosis, suggesting an adverse effectThe peroxisome proliferator-activated receptor (PPAR) α agonist fenofibrate suppresses chemically induced lung alveolar proliferative lesions in male obese hyperlipidemic mice.Fenofibrate attenuated glucose-induced mesangial cells proliferation and extracellular matrix synthesis via PI3K/AKT and ERK1/2.Danqi Pill regulates lipid metabolism disorder induced by myocardial ischemia through FATP-CPTI pathway.Wedelolactone Regulates Lipid Metabolism and Improves Hepatic Steatosis Partly by AMPK Activation and Up-Regulation of Expression of PPARα/LPL and LDLRPaediatric type III dyslipidaemia: a case of vanishing hyperlipidaemia.Fermentation of Green Tea with 2% Aquilariae lignum Increases the Anti-Diabetic Activity of Green Tea Aqueous Extracts in the High Fat-Fed Mouse.PPAR-α Agonist Fenofibrate Decreased Serum Irisin Levels in Type 2 Diabetes Patients with Hypertriglyceridemia.Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress.Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence.PPAR-α as a key nutritional and environmental sensor for metabolic adaptation.Fenofibrate improves endothelial function and plasma myeloperoxidase in patients with type 2 diabetes mellitus: an open-label interventional study.AS04-adjuvanted human papillomavirus (HPV) types 16 and 18 vaccine (Cervarix®): a review of its use in the prevention of premalignant cervical lesions and cervical cancer causally related to certain oncogenic HPV types.Cardiometabolic impact of non-statin lipid lowering therapies.From 'Make in India' to 'Made in India': the saroglitazar story.In vivo interactions between α7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α: Implication for nicotine dependence.A general approach to intermolecular carbonylation of arene C-H bonds to ketones through catalytic aroyl triflate formation.Hepatic AQP9 expression in male rats is reduced in response to PPARα agonist treatment.Anticancer Properties of Fenofibrate: A Repurposing Use.
P2860
Q27325516-DECC3522-76F7-4A89-8CBE-F2E960E5150DQ28652238-A11560F5-87A1-44F0-A00D-35BFB9FB54BAQ30248492-EE9C468F-537D-436C-8250-E67084572571Q33753420-541D2412-418D-46B9-A0E2-2910B17A8EABQ33755975-1C5AFBFC-87A3-46A9-A634-07DB4DEA77EAQ35018587-459CBE08-968A-49DF-93F7-31DABC3FBC44Q35163413-CBB0C2E6-C725-4222-80D5-BC12CE41BFB0Q35689614-95C80A53-2C9C-41D4-A5FE-D65362C1973FQ35980075-2CD42CB7-808A-470B-9970-A0BA7A6ACF70Q36329786-7B08D07A-6405-4BD2-B74F-2518CC76805CQ36360452-60F187CF-6520-4C3D-B24C-3FF5AD11382CQ36867522-14A40ABF-209C-45A3-B3C7-B78C4AB6E839Q36939862-58FDF30B-9950-4836-A4DB-2A7A105BFB12Q37616202-323AC9B8-4960-42B0-B70F-4A42DDA48852Q37681585-9625380D-6BC5-40AB-84B3-F2D24A5CD5DAQ37851958-9D7E528A-079F-446E-B419-FFD68ECC3D0EQ38176275-46A0A6FF-B441-45C3-8630-C2679979F610Q42559674-332D6641-4601-4400-93D3-E2141CCAAF82Q45054305-C914581E-33E8-4417-975F-CCB44442136DQ48044347-817D27B4-05F9-4ED2-B0E4-2589CF1DC744Q51311401-5B059C11-281A-4B84-8202-81482050A73CQ55021652-B654B7A4-F4E5-4863-BFFF-F50CEB7F4FDE
P2860
Fenofibrate: a review of its lipid-modifying effects in dyslipidemia and its vascular effects in type 2 diabetes mellitus.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Fenofibrate: a review of its l ...... s in type 2 diabetes mellitus.
@ast
Fenofibrate: a review of its l ...... s in type 2 diabetes mellitus.
@en
type
label
Fenofibrate: a review of its l ...... s in type 2 diabetes mellitus.
@ast
Fenofibrate: a review of its l ...... s in type 2 diabetes mellitus.
@en
prefLabel
Fenofibrate: a review of its l ...... s in type 2 diabetes mellitus.
@ast
Fenofibrate: a review of its l ...... s in type 2 diabetes mellitus.
@en
P2860
P1476
Fenofibrate: a review of its l ...... s in type 2 diabetes mellitus.
@en
P2860
P304
P356
10.2165/11207690-000000000-00000
P577
2011-08-01T00:00:00Z
P6179
1038790214